“…Dr. Chang, University of California at Riverdale, provided 4 models: "ACEA" -endocannabinoid model, "HU-210" -classical core model, "SR-141716A" -inverse agonist model and "WIN-55,212-2" -non-classical agonist model. 249 The KM series of compounds, I believe, adopt a similar binding mode within the LBP to that of HU-210, thus this was the model used for docking studies. Since it is a very flexible residue in the LBP, it can manifest conformations that allow it to hydrogen bond with either the C-1 hydroxyl, C-11 ("Northern") hydryoxyl, C-6 ("Southern") hydroxyl or even the benzochromene oxygen.…”